VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity (Business Wire via Yahoo! Finance)
MOUNTAIN VIEW, Calif.----VIVUS, Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it has completed an end of phase 2 meeting with the United States Food and Drug Administration for Qnexa.

Scientists Rubbish Official Claim GE Corn is Safe (Scoop.co.nz)
Official claims that illegal GM maize accidentally grown in the US for the past 4 years is "safe" are being challenged by independent scientists in the UK and New Zealand.